So this is an S1 for Oasis to sell 1,700,000 shares of stock at a maximum price of $4. This is an NGIO S1, so just wondering why Oasis is selling GNBT shares under NGIO filing?
https://www.sec.gov/Archives/edgar/data/18045...forms1.htm
CALCULATION OF REGISTRATION FEE
Each Class of
Securities to be Registered Amount to be
Registered(1) Proposed
Maximum
Offering Price
per Share(2) Proposed Maximum
Aggregate Offering Price Amount of
Registration Fee(3)
Shares of Common Stock, par value $0.001 per share 1,700,000 $ 4.00 $ $6,800,000 $ 882.64
(1) Represents shares offered by the selling stockholders. Pursuant to Rule 416 under the Securities Act of 1933, as amended, the shares being registered hereunder include such indeterminate number of shares of common stock, as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.
(2) Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(a) under the Securities Act of 1933.
This prospectus relates to the offer and sale of up to 1,700,000 shares of common stock of Generex Biotechnology Corporation, by the selling stockholders.
We are not selling any securities under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders.
https://www.sec.gov/Archives/edgar/data/18045...forms1.htm
CALCULATION OF REGISTRATION FEE
Each Class of
Securities to be Registered Amount to be
Registered(1) Proposed
Maximum
Offering Price
per Share(2) Proposed Maximum
Aggregate Offering Price Amount of
Registration Fee(3)
Shares of Common Stock, par value $0.001 per share 1,700,000 $ 4.00 $ $6,800,000 $ 882.64
(1) Represents shares offered by the selling stockholders. Pursuant to Rule 416 under the Securities Act of 1933, as amended, the shares being registered hereunder include such indeterminate number of shares of common stock, as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.
(2) Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(a) under the Securities Act of 1933.
This prospectus relates to the offer and sale of up to 1,700,000 shares of common stock of Generex Biotechnology Corporation, by the selling stockholders.
We are not selling any securities under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders.
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.
